DG -- A clinical trial of lisdexamfetamine dimesylate found that the drug exhibits a sustained effect on the symptoms of attention deficit hyperactivity disorder (ADHD) throughout the day, according to research presented here at the 2010 Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP).
